Literature DB >> 19940467

Granulomatous Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma: case report and review of the literature.

Hung Chang1, Lee-Yung Shih, Chi-Wei Wang, Wen-Yu Chuang, Chien-Cheng Chen.   

Abstract

Here we report a case of diffuse large B-cell lymphoma who developed granulomatous Pneumocystis jiroveci pneumonia (PJP) after rituximab and combination chemotherapy. The infection presented as a solitary pulmonary nodule (SPN) instead of the commonly seen diffuse ground-glass infiltrates. The diagnosis was made by wedge resection of the nodule. Both the CD4+ lymphocyte count and immunoglobulin level were low. A literature search revealed 14 granulomatous PJP patients with hematological neoplasms, including the present case, which was the first with diffuse large B-cell lymphoma and the only patient receiving rituximab before PJP development. In addition to our report, only one case had previously presented with an SPN. Our experience suggests that granulomatous PJP should be considered a possible etiology when immunocompromised patients develop fever and SPNs. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940467     DOI: 10.1159/000261020

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  8 in total

1.  Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma after Rituximab-containing regimen: two cases of report and literature review.

Authors:  Xu-Qin Jiang; Lei Fang; Xiao-Dong Mei; Xiao-Jing Wang; Ming-Hong Bao
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary cancer center is safe and reveals noncancerous, noninfectious entities as the most common diagnoses.

Authors:  S P Georgiadou; F L Sampsonas; D Rice; J M Granger; S Swisher; D P Kontoyiannis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-16       Impact factor: 3.267

3.  Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome.

Authors:  Mai Sato; Shuichi Ito; Masao Ogura; Koichi Kamei; Isao Miyairi; Ippei Miyata; Masataka Higuchi; Kentaro Matsuoka
Journal:  Pediatr Nephrol       Date:  2012-09-05       Impact factor: 3.714

4.  Single nodular opacity of granulomatous pneumocystis jirovecii pneumonia in an asymptomatic lymphoma patient.

Authors:  Hyun Soo Kim; Kyung Eun Shin; Ju-Hie Lee
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

Review 5.  Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.

Authors:  Xuqin Jiang; Xiaodong Mei; Di Feng; Xiaojing Wang
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

6.  Pneumocystis Pneumonia Presenting as an Enlarging Solitary Pulmonary Nodule.

Authors:  Krunal Bharat Patel; James Benjamin Gleason; Maria Julia Diacovo; Nydia Martinez-Galvez
Journal:  Case Rep Infect Dis       Date:  2016-08-28

7.  Pneumocystis jirovecii pneumonia in non-Hodgkin's lymphoma after rituximab-based chemotherapy: a case series.

Authors:  Qianying Zhang; Liang Han; Yuanyuan Lin; Xiaohong Sun; Haige Ye; Honglan Qian; Lan Sun; Songfu Jiang; Bin Liang
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

Review 8.  Detection of microorganisms in granulomas that have been formalin-fixed: review of the literature regarding use of molecular methods.

Authors:  Jeannette Guarner
Journal:  Scientifica (Cairo)       Date:  2012-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.